Paper24920907
Multifunctional materials for bone cancer treatment.
Marques C and 5 others. Int J Nanomedicine, 2014. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Multifunctional materials for bone cancer treatment. Papers, record 24920907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24920907
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bone Neoplasms | Major topic |
| Bone Substitutes | Major topic |
| Nanocapsules | Major topic |
| Tissue Scaffolds | Major topic |
| Animals | |
| Combined Modality Therapy | |
| Equipment Design | |
| Humans |
Source PubMed
References122
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22432577 | Polymers for drug delivery systems. | Annu Rev Chem Biomol Eng | 2010 | https://conductscience.org/library/papers/22432577 | PubMed |
| 2 | 19155065 | The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. | Biomaterials | 2009 | https://conductscience.org/library/papers/19155065 | PubMed |
| 3 | 22512444 | Bioresorbable and nonresorbable polymers for bone tissue engineering. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22512444 | PubMed |
| 4 | 22213565 | Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. | J Biomed Mater Res A | 2012 | https://conductscience.org/library/papers/22213565 | PubMed |
| 5 | 22419871 | Cell responses to two kinds of nanohydroxyapatite with different sizes and crystallinities. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22419871 | PubMed |
| 6 | 22005331 | Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite. | Acta Biomater | 2012 | https://conductscience.org/library/papers/22005331 | PubMed |
| 7 | 22177219 | Synthesis and spectroscopic characterization of magnetic hydroxyapatite nanocomposite using ultrasonic irradiation. | Spectrochim Acta A Mol Biomol Spectrosc | 2012 | https://conductscience.org/library/papers/22177219 | PubMed |
| 8 | 15020158 | Bioresorbable composite bone paste using polysaccharide based nano hydroxyapatite. | Biomaterials | 2004 | https://conductscience.org/library/papers/15020158 | PubMed |
| 9 | 16278014 | Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: a porcine model assessed at 18, 24, and 36 weeks. | Biomaterials | 2006 | https://conductscience.org/library/papers/16278014 | PubMed |
| 10 | 20655397 | A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. | Acta Biomater | 2011 | https://conductscience.org/library/papers/20655397 | PubMed |
| 11 | 20039697 | Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery. | ACS Nano | 2010 | https://conductscience.org/library/papers/20039697 | PubMed |
| 12 | 1314896 | Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. | J Orthop Res | 1992 | https://conductscience.org/library/papers/1314896 | PubMed |
| 13 | 22029448 | Bone tissue engineering: current strategies and techniques--part I: Scaffolds. | Tissue Eng Part B Rev | 2012 | https://conductscience.org/library/papers/22029448 | PubMed |
| 14 | 15860204 | Porosity of 3D biomaterial scaffolds and osteogenesis. | Biomaterials | 2005 | https://conductscience.org/library/papers/15860204 | PubMed |
| 15 | 18560766 | Evaluation of CaO-SiO2-P2O5-Na2O-Fe2O3 bioglass-ceramics for hyperthermia application. | J Mater Sci Mater Med | 2009 | https://conductscience.org/library/papers/18560766 | PubMed |
| 16 | 18164931 | Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology. | Eur J Pharm Biopharm | 2008 | https://conductscience.org/library/papers/18164931 | PubMed |
| 17 | 28788309 | Calcium Orthophosphate-Based Bioceramics. | Materials (Basel) | 2013 | https://conductscience.org/library/papers/28788309 | PubMed |
| 18 | 9527282 | The controlled release of antibiotic by hydroxyapatite: anionic collagen composites. | Artif Organs | 1998 | https://conductscience.org/library/papers/9527282 | PubMed |
| 19 | 16680714 | Effect of nanostructure on biodegradation behaviors of self-setting apatite/collagen composite cements containing vitamin K2 in rats. | J Biomed Mater Res B Appl Biomater | 2006 | https://conductscience.org/library/papers/16680714 | PubMed |
| 20 | 19100794 | Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. | J Control Release | 2009 | https://conductscience.org/library/papers/19100794 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40332455 | Secretome Release During In Vitro Bone Marrow-Derived Mesenchymal Stem Cell Differentiation Induced by Bio-Oss® Collagen Material. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332455 | PubMed |
| 39883285 | Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment. | Discov Nano | 2025 | https://conductscience.org/library/papers/39883285 | PubMed |
| 38251150 | Graphene Oxide (GO) for the Treatment of Bone Cancer: A Systematic Review and Bibliometric Analysis. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38251150 | PubMed |
| 38149015 | Bifunctional bone substitute materials for bone defect treatment after bone tumor resection. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/38149015 | PubMed |
| 37091350 | Biomaterial-assisted tumor therapy: A brief review of hydroxyapatite nanoparticles and its composites used in bone tumors therapy. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37091350 | PubMed |
| 36903753 | Smart Magnetic Drug Delivery Systems for the Treatment of Cancer. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/36903753 | PubMed |
| 36660426 | Multifunctional inorganic biomaterials: New weapons targeting osteosarcoma. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36660426 | PubMed |
| 36499342 | Multifunctional Scaffolds Based on Emulsion and Coaxial Electrospinning Incorporation of Hydroxyapatite for Bone Tissue Regeneration. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499342 | PubMed |
| 35221796 | Collagen mineralization with lepidocrocite via Fe(OH)2 addition. | CrystEngComm | 2022 | https://conductscience.org/library/papers/35221796 | PubMed |
| 35163424 | Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163424 | PubMed |
| 34572032 | Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells. | Cells | 2021 | https://conductscience.org/library/papers/34572032 | PubMed |
| 34360979 | Innovative Biomaterials for the Treatment of Bone Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360979 | PubMed |
| 34206757 | Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34206757 | PubMed |
| 34161069 | Time-Resolved Cryo-TEM Study on the Formation of Iron Hydroxides in a Collagen Matrix. | ACS Biomater Sci Eng | 2021 | https://conductscience.org/library/papers/34161069 | PubMed |
| 33997503 | MoS2-based nanocomposites for cancer diagnosis and therapy. | Bioact Mater | 2021 | https://conductscience.org/library/papers/33997503 | PubMed |
| 33445513 | Advances in Osteoporotic Bone Tissue Engineering. | J Clin Med | 2021 | https://conductscience.org/library/papers/33445513 | PubMed |
| 32903812 | Enhancing ZnO-NP Antibacterial and Osteogenesis Properties in Orthopedic Applications: A Review. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/32903812 | PubMed |
| 32367204 | Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers. | J Mater Sci Mater Med | 2020 | https://conductscience.org/library/papers/32367204 | PubMed |
| 32013377 | Controlled Delivery of Curcumin and Vitamin K2 from Hydroxyapatite-Coated Titanium Implant for Enhanced in Vitro Chemoprevention, Osteogenesis, and in Vivo Osseointegration. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32013377 | PubMed |
| 31799249 | Adult Stem Cells for Bone Regeneration and Repair. | Front Cell Dev Biol | 2019 | https://conductscience.org/library/papers/31799249 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24920907
GET https://conductscience.org/api/papers/v1/24920907/references?page=2